Skip to content
karyopharm-logo
Logo for Karyopharm
Main Menu
Contact
Clinical Trials
Careers
Follow Us
LinkedIn
Twitter
Search
About
Show submenu
About Karyopharm
Management Team
Board of Directors
Scientific Advisory Board
Careers
Science
Show submenu
SINE Technology (Selective Inhibitor of Nuclear Export)
Pipeline
Our Medicines
Patients
Show submenu
Overview
SINE Technology
Multiple Myeloma
Diffuse Large B-Cell Lymphoma (DLBCL)
Clinical Trials
Patient Resources
Responsibility
Show submenu
Supporting Medical Research
Expanded Access
Grants & Giving
Corporate Sustainability
Investors & Media
Show submenu
Corporate Profile
Press Releases
Media Assets
Events & Presentations
Corporate Governance
Management Team
Board of Directors
Committee Composition
Contact the Board
Show submenu
Management Team
Board of Directors
Committee Composition
Contact the Board
Financial Information
Show submenu
SEC Filings
Annual Reports & Proxy Statements
Analyst Coverage
Investor FAQs
Publications and Presentations
Corporate Sustainability
Contact Us
Show submenu
Investor Alerts
Corporate Governance
>
Committee Composition
Commercialization and Portfolio Committee
Chair
Christy Oliger
Member
Mansoor Raza Mirza, MD
Member
Deepa R. Pakianathan, PhD
Member
Zhen Su
Agree to Our Terms of Use
I Agree
*
I agree to the storing and processing of my personal data by Karyopharm as described in the
Privacy Policy
and to the
Terms of Use
. I agree to receive communications from Karyopharm and understand that I can unsubscribe at any time.
Chair
Member